--2025/Q1-- / 50.000K--
--2024/Q4-- / 48.770K--
--2024/Q386.000K / 49.580K--
--2024/Q272.000K / 91.690K--
May 8, 20242024/Q172.000K / 79.830K--
Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
VRDN Viridian Therapeutics
- 17.850
- -0.140-0.78%
Close Dec 13 16:00 ET
- 20.000
- +2.150+12.04%
Post 20:01 ET
1.41BMarket Cap-4.13P/E (TTM)
17.990High17.250Low1.56MVolume17.830Open17.990Pre Close27.46MTurnover1.97%Turnover RatioLossP/E (Static)79.21MShares27.20052wk High2.73P/B1.41BFloat Cap11.40052wk Low--Dividend TTM79.15MShs Float2247.750Historical High--Div YieldTTM4.11%Amplitude4.665Historical Low17.615Avg Price1Lot Size
Viridian Therapeutics Key Stats
Viridian Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Viridian Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data